Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 642 of 1,261

  1. US 9605259

    Compounds and methods for modulating protein expression

    Ionis Pharmaceuticals, Inc. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  2. US 9605057

    Endotrophin neutralization and use thereof

    The Board of Regents of the University of Texas System · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  3. US 9605054

    Composition and method for treating a tauopathy

    Northwestern University · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  4. US 9605042

    Compositions and methods related to tauopathy

    Regents of the University of Minnesota · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  5. US 9605026

    Hydrogen-bond surrogate peptides and peptidomimetics for p53 reactivation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  6. US 9605044

    Methods and compositions for modulating immune tolerance

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  7. US 9605000

    Spiro azetidine isoxazole derivatives and their use as SSTR antagonists

    Takeda Pharmaceutical Company Limited · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  8. US 9604901

    Process to prepare treprostinil, the active ingredient in Remodulin®

    United Therapeutics Corporation · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  9. US 9604976

    Antibacterial compounds

    SPERO GYRASE, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  10. US 9604973

    Anti-cancer polyketide compounds

    The Regents of the University of California · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  11. US 9603954

    Methods for generating radioimmunoconjugates

    Actinium Phamaceuticals, Inc. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  12. US 9603949

    Oligonucleotide-based probes for detection of bacterial nucleases

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  13. US 9603907

    Dry powder formulations of dNase I

    Protalix Ltd. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  14. US 9603895

    Cyclosporin analogues for preventing or treating hepatitis C infection

    Enanta Pharmaceuticals, Inc. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  15. US 9603945

    Heparosan polymers and methods of making and using same for the enhancement of therapeutics

    The Board of Regents of the University of Oklahoma · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  16. US 9603896

    Peptide compounds and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  17. US 9603806

    Pharmaceutical compositions for the treatment of Helicobacter pylori

    RedHill Biopharma Ltd. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  18. US 9603829

    HSP90 inhibitors with modified toxicity

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  19. US 9603824

    Compositions and methods for controlling infections

    Regents of the University of Minnesota · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  20. US 9603781

    Skin cleaning kit

    Coviden LP · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  21. EP 3144307

    NEUE OXAZOL DERIVATEN ALS SYK KINASEHEMMER

    AB SCIENCE [FR] · Granted Mar 22, 2017 · Expires Mar 17, 2037

    granted

  22. US 9598404

    Deoxycytidine kinase inhibitors

    The Regents of the University of California · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

  23. US 9598370

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

  24. US 9598454

    Mannose derivatives for treating bacterial infections

    Vertex Pharmaceuticals Incorporated · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.